Assessing the Effects of the Muse Meditation System on Cognition and Well-being

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

May 1, 2022

Study Completion Date

December 1, 2022

Conditions
Cognitive Change
Interventions
DEVICE

Muse

Interaxon markets a head-worn EEG biofeedback device ('Muse') to encourage and aid effective meditation and sleep. This device has been previously shown to improve workplace wellness, fatigue and quality of life, and performance on the Stroop Task. It has also been shown to improve physiological markers associated with improved relaxation. Muse has been shown to have an EEG signal comparable to a clinical grade EEG.

BEHAVIORAL

Meditation Coaching

Participants will be asked to use the Muse Meditation system for a minimum of 5 minutes a day (in one or multiple sessions), a minimum of 5 days a week, for 6 weeks and will be coached in how to do so. Coaches will be versed in Mindfulness and how to use Muse. Coaching will take place virtually using Interaxon's Zoom account.

Trial Locations (1)

Unknown

Western University, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

InteraXon, Inc.

INDUSTRY

collaborator

Cambridge Brain Sciences

INDUSTRY

lead

Western University, Canada

OTHER

NCT04790929 - Assessing the Effects of the Muse Meditation System on Cognition and Well-being | Biotech Hunter | Biotech Hunter